Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Everts-Graber

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 22, 2022
Bone Mass Gains After One Denosumab Injection Followed by ZoledronateJudith Everts-Graber, Thomas Lehmann
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 1: Antiresorptive and osteoanabolic therapy options]Serge Ferrari, Judith Everts-Graber, Christian Meier
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 2: Sequential osteoporosis therapy]Christian Meier, Judith Everts-Graber, Serge Ferrari
Aging Clinical and Experimental Research|March 7, 2025
Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approachOlivier Lamy, Judith Everts-Graber, Elena Gonzalez Rodriguez
Revue Medicale Suisse|April 17, 2025
[Clinical efficacy of osteoporosis treatments]Serge Ferrari, Christian Meier, Judith Everts-Graber, et al.
Revue Medicale Suisse|April 17, 2025
[Sequential drug treatments for osteoporosis]Olivier Lamy, Christian Meier, Judith Everts-Graber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2020
A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass GainsJudith Everts-Graber, Stephan Reichenbach, Hans Rudolf Ziswiler, et al.
Arthritis Care & Research|September 27, 2017
Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III TrialBurkhard Möller, Judith Everts-Graber, Stefan Florentinus, et al.
Bone|July 26, 2022
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world settingJudith Everts-Graber, Stephan Reichenbach, Brigitta Gahl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2024
Fracture risk prediction in postmenopausal women with traditional and machine learning models in a nationwide, prospective cohort study in Switzerland with validation in the UK BiobankOliver Lehmann, Olga Mineeva, Dinara Veshchezerova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 22, 2022
Bone Mass Gains After One Denosumab Injection Followed by ZoledronateJudith Everts-Graber, Thomas Lehmann
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 1: Antiresorptive and osteoanabolic therapy options]Serge Ferrari, Judith Everts-Graber, Christian Meier
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 2: Sequential osteoporosis therapy]Christian Meier, Judith Everts-Graber, Serge Ferrari
Aging Clinical and Experimental Research|March 7, 2025
Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approachOlivier Lamy, Judith Everts-Graber, Elena Gonzalez Rodriguez
Revue Medicale Suisse|April 17, 2025
[Clinical efficacy of osteoporosis treatments]Serge Ferrari, Christian Meier, Judith Everts-Graber, et al.
Revue Medicale Suisse|April 17, 2025
[Sequential drug treatments for osteoporosis]Olivier Lamy, Christian Meier, Judith Everts-Graber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2020
A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass GainsJudith Everts-Graber, Stephan Reichenbach, Hans Rudolf Ziswiler, et al.
Arthritis Care & Research|September 27, 2017
Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III TrialBurkhard Möller, Judith Everts-Graber, Stefan Florentinus, et al.
Bone|July 26, 2022
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world settingJudith Everts-Graber, Stephan Reichenbach, Brigitta Gahl, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2024
Fracture risk prediction in postmenopausal women with traditional and machine learning models in a nationwide, prospective cohort study in Switzerland with validation in the UK BiobankOliver Lehmann, Olga Mineeva, Dinara Veshchezerova, et al.
Pageof 2